Cramer's TheStreet.com TV

Return to Article

Cramer's TheStreet.com TV Recap: Laggard Relief

TheStreet.com Staff

"Let's talk laggards and companies that have been trapped by the strike," Jim Cramer said on his TheStreet.com TV video Webcast Monday.

Cramer cited Goldman Sachs (GS Quote) and AIG (AIG Quote), two companies he owns for his Action Alerts PLUS charitable trust, as strike laggards that are now breaking out.

Despite "unbelievable" pressure on Goldman Sachs, the stock is now "free to romp," Cramer said. "In the last hour, I saw about 400,000 shares just trying to pin the stock. It was too good of a trade. Could 400,000 shares really be the difference? Yes, if it's relentless and it keeps knocking out the bid, which is what you do when you're making that trade," he said. The buyback usually comes in five days after, said Cramer, which would be tomorrow. He advised getting ahead of the buyback.

AIG, which Cramer said is the cheapest in the insurance group, is another stock that's been held back but is now breaking out. He believes this move is happening for two reasons: former CEO Hank Greenberg has been selling his stock relentlessly and people feel regulators are going to be "all over them" again. But Cramer believes it's not a worry as the company has a clean bill of health from Eliot Spitzer.

In other market news:

• Cramer said that despite the fact it had been hung at the $85 level, Altria (MO Quote) is also "free to romp" at this point, and that any second we are going to see the company's expected breakup. This will probably occur before year's end, according to Cramer.
• AT&T's (T Quote) deal to merger with Bell South (BLS Quote) could close this week, according to Cramer.
• This week we'll get news word of Philadelphia on Trump (TRMP Quote), and Cramer believes its project will be big news for the city's north end, where jobs are needed.
• Cramer still doesn't like drug stocks, and said he doesn't believe the recent news that Eli Lilly's (LLY Quote) Zyprexa drug makes people gain weight is relevatory or will result in a class action suit. He advised not to worry about this one.
• He did encourage people to take a look at Johnson & Johnson (JNJ Quote), which is acquiring Pfizer's (PFE Quote) consumer products division. You won't get the benefits of the Pfizer (PFE Quote) deal, he warned. "Remember, Pfizer didn't know how to market anything -- still don't, that's why those guys are starting to be called clowns. JNJ knows how to market better than anyone," he said. Cramer expects this stock is headed for $70.